Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv save search
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
rinvoq positive cell results study
Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027, Technavio
Published: 2024-04-17 (Crawled : 00:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
therapeutics market
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
AbbVie to Host First-Quarter 2024 Earnings Conference Call
Published: 2024-04-04 (Crawled : 12:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.86%
H: 0.03%
C: -5.49%
conference abbvie
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NXGL | $2.21 -1.4% 1.2K
|
Manufacturing
|
| O: 1.83%
H: 0.0%
C: -19.42%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.12%
H: 0.01%
C: -0.62%
year revenue
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
research global
Flooring Market size to record USD 84.98 bn growth from 2024-2028, Increasing demand for waterproof flooring is one of the key market trends, Technavio
Published: 2024-03-27 (Crawled : 23:00) - prnewswire.com
ITOCF | $43.49 3.01% 21K
|
Distribution Services
|
| O: 0.21%
H: 0.09%
C: 0.09%
ITOCY | $85.09 0.0% 33K
|
Real Estate and Rental and Leas...
|
| O: -0.75%
H: 0.14%
C: -0.18%
RPM | $106.57 -0.75% 0.0% 630K
|
Process Industries
|
| O: -0.05%
H: 0.52%
C: -0.97%
AWI | $113.98 0.11% 0.03% 220K
|
Producer Manufacturing
|
| O: 0.06%
H: 0.5%
C: -0.26%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
one key growth market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
NIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
nx-13 candidate precision biopharma acquisition platform
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE
Published: 2024-03-25 (Crawled : 20:00) - prnewswire.com
LABP | $21.74 -0.05% -0.05% 15K
|
|
| O: -0.09%
H: 0.69%
C: -0.42%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.39%
H: 0.3%
C: -0.02%
XOMA | News | $24.97 1.55% 1.52% 17K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: -3.58%
FUSN | $21.26 0.05% 0.05% 440K
|
Health Technology
|
| O: 0.38%
H: 0.28%
C: 0.19%
Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
LABP | $21.74 -0.05% -0.05% 15K
|
|
| O: 176.76%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
LABP | $21.74 -0.05% -0.05% 15K
|
|
| O: 176.76%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.19%
H: 0.11%
C: -0.26%
abbvie acquire
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
elahere drug approval food cancer grants
Waste Management Market to grow by USD 167.1 billion, laws in Europe for recycling waste to boost market growth, Technavio
Published: 2024-03-22 (Crawled : 18:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
europe management market
Air Purifier Market to grow by USD 5.58 billion from 2023 to 2027, 3M Co. and AustinAir to emerge as some of the key companies, Technavio
Published: 2024-03-22 (Crawled : 17:00) - prnewswire.com
DKILF | News | $123.75 25.48% 1.4K
|
Producer Manufacturing
|
| O: -2.72%
H: 5.33%
C: 1.01%
DKILY | News | $12.515 -0.07% 760K
|
Manufacturing
|
| O: -1.6%
H: 3.63%
C: 0.44%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -1.23%
H: 0.7%
C: -0.6%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: 0.07%
H: 0.22%
C: -0.39%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.16%
H: 0.32%
C: -0.44%
air key market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.